Harte-Hanks (NASDAQ:HHS) reported quarterly sales of $54.80 million which beat the analyst consensus estimate of $52.20 million by 4.98 percent. This is a 5.41 percent increase over sales of $51.99 million the same period last year.
Related Posts
Haoxi Health Technology Limited Enters Into Rebate Agreement With Clients On Advertising Placement Campaign
Haoxi Health Technology Limited (the "Company" or "HAO"), an online marketing solution provider headquartered in Beijing, China, today announced that Beijing Haoxi Digital Technology Co., Ltd. ("Haoxi Beijing"), a
Conduent’s BenefitWallet HSA Portfolio Moving To HealthEquity; The Agreement Contemplates A Purchase Price Of ~$425M For The Transition Of All BenefitWallet HSA Accounts
Conduent Incorporated (NASDAQ:CNDT), a global technology-led business solutions and services company, and HealthEquity, Inc. (NASDAQ:HQY), the nation's largest health savings account (HSA) administrator, today announced
Why Is Vivek Ramaswamy-Founded Roivant Sciences Stock Trading Lower Today?
Roivant Sciences Ltd (NASDAQ: ROIV) and Priovant's Phase 2 study of oral brepocitinib in moderate to severe active lupus did not meet its primary endpoint of Systemic Lupus Erythematosus (SLE)